Summary

Robert F. Kennedy Jr. vowed to overhaul parts of the FDA, specifically targeting the agency’s nutrition department, which he claims “are not doing their jobs” and failing to protect public health.

Kennedy, a known opponent of vaccinations and the pharmaceutical industry, said he could “clear out” corruption in health agencies. President-elect Donald Trump has indicated he would give Kennedy significant influence over health policy, though Trump’s campaign denied he would lead HHS.

Experts and family members warn that Kennedy’s anti-vaccine stance could have serious public health repercussions.

  • catloaf@lemm.ee
    link
    fedilink
    English
    arrow-up
    5
    ·
    15 days ago

    I’m not sure that vaccines are actually profitable without subsidies. They’d probably rather milk their cash cows like price-gouged insulin and trendy medications like ozempic.

    • _thebrain_
      link
      fedilink
      arrow-up
      6
      arrow-down
      1
      ·
      15 days ago

      Afaik profit is profit whether it’s from subsidies or sales. On top of that, the government gave them grants to develop said vaccines, so r&d was highly discounted… Production of most vaccines as way cheap compared to r&d, so I doubt there is ever any “selling for a loss”. Combine that with state mandates requiring kids to get vaccines before attending school (I’m not saying this is bad… Public health is a good thing), and you have a captive customer base.

    • _thebrain_
      link
      fedilink
      arrow-up
      3
      arrow-down
      1
      ·
      15 days ago

      Afaik profit is profit whether it’s from subsidies or sales. On top of that, the government gave them grants to develop said vaccines, so r&d was highly discounted… Production of most vaccines as way cheap compared to r&d, so I doubt there is ever any “selling for a loss”. Combine that with state mandates requiring kids to get vaccines before attending school (I’m not saying this is bad… Public health is a good thing), and you have a captive customer base.